Syncrosome at Bio2019 Come and meet Syncrosome at #BIO2019 booth #2109. Syncrosome invites you to visit us at BioConvention, June 3rd to June 7th 2016, in Philadelphia, USA. Emmanuelle Bettendorf, our Account Manager would be delighted to meet you their and discuss your in vivo preclinical projects. We...
SYNCROSOME your dedicated partner for In Vivo Efficacy Studies has been accepted for a poster presentation at NeuroFrance 2019 (Marseille, France, 22-24 May) which is an International Meeting from Société des Neurosciences. Thanks to its CNS expertise our CNS Study Monitor, Dr. Delphine Revy, will present several...
See you soon in Rotterdam (20-22 May, 2019) to exchange on Gastrointestinal, Cardiovascular and Central Nervous System diseases.Let's stay tuned and we will give you more details on our talk, booth and possibility to meet their! ...
As you know Syncrosome is a preclinical CRO managing efficacy in vivo/ in vitro studies with more than 15 disease models validated in house and highly reproducible. Syncrosome is involved in Central Nervous System activities for 16 years with a specific department dedicated to several CNS...
We wish you Health, Happiness and Prosperity throughout the New year!! ...
The 6ThDrug Discovery Innovation Programme will feature 2 days of interactive presentations, poster presentation and networking opportunity, in Frankfurt (Germany) from 29 to 30thof October. This conference will offer a complete programme focusing on preclinical animal models, breakthrough technologies : Target engagement Advances in medicinal...
Multiple studies have been performed to evaluate the effects of mesenchymal stem cells (MSCs) in preclinical Parkinson models. We performed a meta-analysis to estimate the treatment effect of unmodified MSCs on behavioral outcomes in preclinical studies of Parkinson's disease (PD). We performed a systematic literature search...
The 4th Microbiome R&D and Business collaboration Forum will feature 2 days of interactive presentations, poster presentation and networking opportunity, in Amsterdam (Netherlands) from 3 to 4th of April. This conference will offer a complete programme focusing on preclinical animal model and specific focuses : Probiotics and Digestive Health (Roles...
Myocardial infarction (MI) or acute myocardial infarction (AMI), commonly known as a heart attack, occurs when blood flow stops to a part of the heart causing damage to the heart muscle. It results from a biphasic ischemia/reperfusion (I/R) injury to the heart. Despite considerable effort,...
Syncrosome invites you to visit us at 2nd Annual Neuroscience Biopartnering & Investment Forum, March 27th to March 28th, In New-York, USA. The Forum will be focused on Neurodegenerative Diseases with a mix of specialist panels and company presentations. It will be the occasion for Syncrosome to...